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Abstract
Chronic hepatitis B and C virus (HBV and HCV) infections are among the leading causes of 
preventable death worldwide. Chronic viral hepatitis is the cause of most primary liver cancer, 
which is the third leading cause of cancer deaths globally and the ninth leading cause of cancer 
deaths in the U.S. The extent to which Comprehensive Cancer Control (CCC) programs in states, 
tribal governments and organizations, territories, and Pacific Island jurisdictions address chronic 
hepatitis B and/or hepatitis C infections as risk factors for liver cancer or recommend interventions 
for liver cancer prevention in their CCC plans remains unknown. We searched CCC plans for this 
information using the search tool at http://www.cdc.gov/cancer/ncccp/ to access the content of 
plans for this information. A combination of key search terms including “liver cancer,” “hepatitis,” 
“chronic alcohol,” and “alcohol abuse” were used to identify potential content regarding liver 
cancer risk factors and prevention. Relevant content was abstracted for further review and 
classification. Of 66* CCC plans, 27% (n=18) addressed liver cancer using the above-mentioned 
search terms. In the 23 plans that addressed HBV and/or HCV, there were 25 goals, objectives, 
strategies, and outcomes aimed at reducing the incidence or prevalence of HBV and/or HCV 
infection. While nearly a third of CCC programs identify at least one goal, objective, strategy, 
outcome, or prevention program to reduce cancer burden in their CCC plans, few plans discuss 
specific actions needed to reduce the burden of liver cancer.
Keywords
liver cancer; hepatitis; chronic alcohol; alcohol abuse; comprehensive cancer control plans
*Although CDC funds 65 programs, one of the Pacific Island Jurisdiction grantees is the Federated States of Micronesia (FSM). This 
national program supports four FSM states, each of which submits a cancer plan to CDC for a total of 69 plans. During this time 
period, 66 plans were available on the website.
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Introduction
Liver cancer, primarily hepatocellular carcinoma (HCC), is the third leading cause of death 
from cancer worldwide and the ninth leading cause of cancer deaths in the United States (1). 
HCC incidence tripled in the United States from 1975 through 2005, with the highest 
incidence among Asian/Pacific Islanders (A/PIs) who immigrated to the United States (2). 
Chronic hepatitis B and C infections are risk factors for liver cancer, resulting in cirrhosis 
and eventually HCC (3). In the United States, an estimated 3,000 people die each year from 
chronic liver disease deaths associated with HBV infections and 12,000 people die annually 
from HCV infections (4). Only about half the adults who are at high risk for HBV infection 
have received the hepatitis B vaccine (3). Development of viral hepatitis services, including 
screening with care referral for persons chronically infected with HBV or HCV, full 
implementation of vaccine-based strategies to eliminate hepatitis B, and improved public 
health surveillance are needed to help reverse the trend in HCC incidence (1).
In 1998, the Centers for Disease Control and Prevention (CDC) provided funding to five 
states and one tribal health board that had existing comprehensive cancer control (CCC) 
plans (5). Since 1998, the number of programs funded by CDC through the National 
Comprehensive Cancer Control Program (NCCCP) has grown from six to 65 (6). Health 
agencies use the funding to establish broad-based CCC coalitions, assess the burden of 
cancer, and develop and implement CCC plans. These plans include interventions to reduce 
cancer incidence and mortality (5).
CCC programs in all 50 states, the District of Columbia, seven tribal governments, and seven 
territories and jurisdictions are challenged to raise awareness and implement interventions to 
prevent and control cancer in their local populations. The objectives of this analysis are: (1) 
to identify the number of NCCCP programs that address liver cancer and/or chronic HBV 
and/or HCV as risk factors for liver cancer in their CCC plans, and (2) to assess the extent to 
which plans provide overall goals and strategies for prevention of both hepatitis and liver 
cancer.
Methods
In June 2010 and July 2010, we reviewed all CCC plans (n=66) posted on the Cancer 
Control P.L.A.N.E.T. website (http://cancercontrolplanet.cancer.gov/). Although CDC funds 
65 programs, one of the Pacific Island Jurisdiction grantees is the Federated States of 
Micronesia (FSM). This national program supports four FSM states, each of which submits 
a cancer plan to CDC for a total of 69 plans. During this time period, 66 plans were available 
on the website. We used a search tool specifically designed to perform plan searches (http://
apps.nccd.cdc.gov/CCCSearch/Default/Default.aspx). A list of key search terms was 
developed that identified language within plans indicating a relation to liver cancer and risk 
factors of liver cancer. Key terms included the following exact phrases or words: liver 
cancer, hepatitis, chronic alcohol, and alcohol abuse. Chronic alcohol and alcohol abuse are 
important risk factors for liver cancer and were therefore selected as key terms; however, due 
to the few programs that addressed them in terms of liver cancer, data is not shown for these 
terms.
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An initial abstraction form template was developed in Microsoft Excel for liver cancer and 
hepatitis to collect information about the context in which each term was referenced in the 
CCC plans. Templates were updated and finalized to include content abstracted from all 
relevant CCC plans. The sentence in the plan related to the term was reviewed for specific 
contextual associations related to liver cancer and hepatitis. If multiple key terms identified 
the same content, the duplicate content was not abstracted. If a CCC plan included any of the 
search terms, but the content was found to be irrelevant for the purpose of this review, it was 
not included in the analysis. Finally, key terms used did not always yield content related to 
liver cancer, as some were found referenced in personal testimonies. This content was either 
not abstracted or removed after later determination of relevance.
The context of each key term was evaluated for whether it appeared in background 
information; as a goal, objective, or strategy/tactic; as a risk factor; as a recommendation 
that will be promoted; or other. Within CCC plans, a goal refers to a specific program 
achievement by a certain time period. An objective refers to a program’s efforts and/or 
actions taken to achieve the goal. A strategy and/or tactic refer to a program undergoing 
specific activities needed to accomplish the goal. An outcome is defined as a program’s 
expected result of their achievement. An initial template, similar to the previous one, was 
created in Microsoft Excel to include each of the described above. After evaluation of each 
term’s content, the template was finalized and content was placed into the template based on 
how it was stated and or placed in the plan.
Due to the few plans addressing this issue, an in-depth, program-level analysis using one 
abstractor was conducted to identify the number of plans addressing liver cancer and 
hepatitis as a major risk factor for liver cancer, along with screening guidelines and 
evidence-based interventions. Qualitative and quantitative data were collected to abstract the 
information. The abstractor used the search function within the documents to locate each 
occurrence of the key term. Once a key term for a specific priority was located, the 
abstractor read the surrounding text to determine of the content was relevant to the analysis. 
When a relevant match was found, the data were abstracted into the appropriate template.
Once the data was abstracted, qualitative and quantitative coding was conducted to develop 
an understanding of program plans to reduce the burden of liver cancer and implement 
activities aimed at preventing the cancer. Categories were created based on a review of the 
data collected and organized into tables for easier understanding of the various types of 
content collected from the plans.
Results
Out of 66 CCC plans, 18 (27%) had content that addressed liver cancer by identifying risk 
factors; the current burden and causes of liver cancer; goals, objectives, and strategies; 
incidence and prevalence; at-risk populations, or in another context (Table 1). Twenty three 
CCC plans (35%) included content related to the term “hepatitis” by identifying hepatitis 
either as a risk factor for cancer; goals, objectives, strategies to reduce the burden of 
hepatitis; or as a preventable measure for hepatitis B and/or C (Table 2). Overall, we 
abstracted 46 content items from the 18 CCC plans related to liver cancer and 47 content 
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items from the 23 CCC plans related to chronic hepatitis B and/or C. Sixty-one percent (n 
=11/18) of content abstracted addressed risk factors that lead to liver cancer, 64% (n=7/11) 
of these plans specifically identified chronic hepatitis B and/or C as a risk factor. Table 3 
provides examples of content items related to interventions, such as awareness campaigns 
and vaccination programs, for liver cancer and indicates where they were found in the plan 
(goal, objective, or strategy). Forty-four percent (n=8/18) of content items related to liver 
cancer addressed the current burden of liver cancer, while only one plan identified future 
steps for addressing liver cancer.
There were 25 items abstracted related to a goal, objective, strategy, or outcome related to 
chronic hepatitis B and/or C infection, with 44% (n=11/25) of CCC plans specifically 
emphasizing at least strategy to reduce the current burden of chronic hepatitis B and/or C. 
Thirty-five percent (n=8/23) of these CCC plans address a prevention and/or vaccination 
program for hepatitis B to reduce the burden of liver cancer. Table 4 provides examples of 
content items in CCC plans related to interventions for hepatitis prevention and indicates 
where the items were found. Three CCC plan contained content related to chronic alcohol; 
however, only one of these plans described it as a risk factor for liver cancer. Ten CCC plans 
include content related to alcohol abuse; however, only four of these linked the relationship 
to cancer, and none of them were linked specifically to liver cancer.
Discussion
It is estimated that HBV and HCV infections cause nearly 1 million deaths each year (7). 
Liver cancer incidence rates continue to increase, which may be due to chronic hepatitis B 
and C infections (3). Our results show that most CCC plans do not address the connection 
between chronic hepatitis B and/or hepatitis C infection and liver cancer. Many chronically 
infected persons are not aware that they have been infected until symptoms of advanced liver 
disease develop (3). Therefore, it is important that CCC plans identify action steps in 
preventing the risk factors associated with liver cancer. Few CCC plans address a prevention 
program to reduce the burden of liver cancer. However, states with large A/PI populations 
were more apt to address liver cancer, and some plans target specific populations including 
American Indian and Alaskan Natives, who have been found to have the highest rate of 
liver-related death of ethnic groups in the United States (8). While a small proportion of 
CCC plans address “liver cancer” and “hepatitis”, a greater need of awareness and evidence-
based interventions need to be developed to address this cancer. According to the 2010 
Institute of Medicine (IOM) Report, a lack of public and provider awareness, as well as a 
lack of public resource allocation are the primary underlying causes of high rates of chronic 
hepatitis B and C in the United States (3). The IOM provides three recommendations for the 
prevention and control of chronic hepatitis B and C, including improved data surveillance, 
improved provider and community education, and integration and enhancement of viral 
hepatitis services (2). In 2010, CDC’s Comprehensive Cancer Control Branch developed six 
priorities to guide the work of grantees funded under the NCCCP and to focus on common 
and cross-cutting elements among programs. Enhancing data collection and reporting of 
incidence, prevalence, and mortality, as well as improving awareness are two cross-cutting 
priorities that will guide interventions and the development and evaluation of comprehensive 
approaches to cancer prevention and control. Data collection and education may increase in 
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the future as programs begin to adapt these priorities and incorporate them into their CCC 
plans.
Limitations
One limitation of this content analysis was that we may have missed relevant content in the 
CCC plans because of the search terms we used. Another limitation is the fact that a single 
abstractor determined what content was relevant and the process was not validated. While 
most qualitative studies have two or more abstractors, due to the few number of plans that 
addressed the issue, as well as the lack of staff support during this time, it was decided that 
one abstractor would be sufficient. Another limitation is that other documents that may have 
been more recent, such as CCC action plans or work plans, were not reviewed. Analysis of 
these other documents could provide greater details as to the current work be done to prevent 
liver cancer. Furthermore, current CCC plans maybe outdated as some programs were 
revising some or all of their plans.
Conclusions
Through review and analysis of liver cancer, chronic hepatitis B, and hepatitis C content in 
the most current available CCC plans, we found that few programs specifically address the 
importance and rising burden of liver cancer. Most CCC programs that mention liver cancer 
in their plans provide background information regarding risk factors associated with the 
cancer and/or a reference to goals and strategies for reducing the current burden. Only one 
CCC plan identifies future steps for addressing liver cancer. While most chronic hepatitis B 
and/or hepatitis C content was related to an objective or strategy for reducing the burden of 
these infections, very few CCC programs identified the preventative measures that would 
lead to lower liver cancer burden. Public health professionals need to find better ways to 
implement and disseminate cost-effective interventions that promote early detection of 
chronic infection to allow for treatment of chronic hepatitis B and/or hepatitis C, thereby 
reducing the incidence of liver cancer. This review highlights an opportunity for technical 
assistance related to increasing awareness of chronic hepatitis as a risk for liver cancer and 
to direct programs to resources and partners to help lessen this burden.
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Table 1
Liver Cancer Related Content in Comprehensive Cancer Control (CCC) Plans (n=18)
Context
Number of
plans
Addresses risk factors as a cause of liver cancer 11
Identifies Hepatitis B/C as a risk factor 7
Addresses current burden of liver cancer 8
Goals/Objectives/Strategies 7
Identifies at least one goal related to liver cancer 1
Identifies at least one objective related to liver cancer 2
Identifies at least one strategy related to liver cancer 5
Addresses cause of death of liver cancer 5
Addresses prevalence and incidence of liver cancer in populations 5
Addresses at-risk populations/disparities/health inequity 4
Discuss liver cancer as background information 3
Addresses liver cancer diagnosis and survival rate after diagnosis 2
Identifies future steps for addressing liver cancer 1
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Table 2
Hepatitis B/C Related Content in Comprehensive Cancer Control Plans (n=23)
Context
Number of
plans
Addresses hepatitis B/C as a risk factor for cancer 14
Identifies Hepatitis as a risk factor primarily for liver cancer 7
Goals/Objectives/Strategies/Tactic/Outcomes 25
Identifies at least one goal related to hepatitis B/C 4
Identifies at least one objective related to hepatitis B/C 6
Identifies at least one strategy related to hepatitis B/C 11
Identifies at least one tactic related to hepatitis B/C 1
Identifies at least one outcome related to hepatitis B/C 3
Addresses a prevention and/or vaccination program to reduce burden 8
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Momin and Richardson Page 9
Table 3
Examples of Goals/Objectives/Strategies for Liver Cancer in CCC plans
Goals
By 2010, increase the survival rate of primary liver cancer by 20%.
By 2010, all A/PI should be screened for hepatitis B to decrease the liver cancer mortality rate among A/PI.
Objectives
Reduce death and illness from liver cancer.
Within 5 years of implementation, increase local diagnostic capability for prostate and liver cancer.
Strategies
Implement a culturally appropriate campaign aimed at A/PI communities and health care providers to increase their awareness about hepatitis B, 
liver cancer, and preventive measures.
Liaise with the Sexually Transmitted Infections (STI) Program to share data and incorporate cancer awareness in its activities emphasizing the 
relationship between hepatitis B, alcohol and liver cancer.
Assess, monitor, promote and provide Hepatitis B vaccination series for people of all ages to prevent one type of liver cancer.
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Table 4
Examples of Goals/Objectives/Strategies/Tactics/Outcomes for Hepatitis B and/or C in CCC plans
Goals
By 2010, reduce hepatitis B infection by 99%.
By 2012, each jurisdiction will achieve completed hepatitis B vaccination series in 90% of 2-year-old children.
Objectives
Assure hepatitis B immunization of all children, teenagers, and adults, especially those of childbearing age or who remain sexually active.
Screen all A/PI for hepatitis B infection, especially those who are foreign born, 18 years of age and under.
Each jurisdiction will achieve completed hepatitis B vaccination series in 90% of 2-year-old children by 2012.
Promote Hepatitis B vaccine for children 19–35 months of age.
Promote Hepatitis B vaccines for at-risk adults accessing STD clinics.
Strategies
Screen all A/PIs for hepatitis B and immunize those who are not protected.
Promote existing hepatitis B immunization program.
Work with Regional Comprehensive Cancer Program to implement HBV vaccination program.
Implement at least two interventions annually to increase the number of children who receive hepatitis B vaccine by the time they enter 
kindergarten.
Provide at least two opportunities annually for people working with middle school children to learn more about viral hepatitis prevention and 
resources.
Increase the proportion of sexually active adults who receive free hepatitis B vaccine by 2010.
Educate health-care providers about how to talk to parents and patients about viral hepatitis and HPV and long-term benefits of the hepatitis B 
and HPV vaccines.
Provide education and awareness of the transmission routes for hepatitis C in order to decrease risky behaviors.
Tactics
Conduct a media campaign that includes culturally and linguistically appropriate materials about what every A/PI should know regarding liver 
cancer and hepatitis B, a Website in Asian languages, and a personally staffed toll-free number.
Expand collaboration to all A/PI groups, health insurers, the Department of Health Services, and policy-makers for funding, monitoring, and 
successful hepatitis B and liver cancer preventive outcomes.
Work with insurance companies and state and federal legislators for hepatitis B immunization coverage for adults.
Provide early treatment of hepatitis B and C infections and screen those with chronic hepatitis for liver cancer.
Make hepatitis B immunization a Health Plan Employer Data and Information Set (HEIDIS) indicator.
Educate health care providers about the need for hepatitis B screening in all A/PI, and educate them about liver cancer, its risk factors, persons 
at risk, and culturally appropriate ways to reach and communicate with their A/PI patient populations.
Outcomes
By 2011, decrease the number of children and adults who contract hepatitis C by 30%.
Immunization rates for hepatitis B will increase by 5%.
J Community Health. Author manuscript; available in PMC 2017 February 02.
